Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

You'll come for the hands-on tweaking and wealth of features, and quickly forgive some of the workflow issues when you hear ...

Abstract: The rapid advancement of the Internet of Underwater Things (IoUT) necessitates robust, high-capacity communication systems that can operate efficiently in the challenging conditions of ...

Abstract: In this paper, the performance of an uncoded multiple-input-multiple-output (MIMO) scheme combining single transmit antenna selection and receiver maximal-ratio combining (the TAS/MRC scheme ...

Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the ...

Because Krea relinquishes centralized control over the downstream deployment of its open weights, the contract legally binds ...

Multiple sclerosis is especially destructive because of its tendency to worsen progressively. Instead of working through the immune system, Quantum BioPharma’s Lucid-MS acts directly on the myelin ...

Fine-scale exogenous attention within the foveola selectively enhances contrast gain at low-to-mid spatial frequencies while increasing response gain across a broad spatial frequency range.

Discusses Clinical Trials Growth Through Indication and Solution Expansion With Focus on Psychiatry and Narcolepsy June 9, ...

Objectives Enteral nutrition (EN) constitutes a critical therapeutic intervention in the management of patients with sepsis; however, the optimal timing for its initiation remains uncertain. This ...

Background Few interventions reduce patellar tendinopathy (PT) pain in the short term. Eccentric exercises are painful and have limited effectiveness during the competitive season. Isometric and ...